Scarica l'app Stockscreener
3.27
4.39%
-0.15
Dopo l'orario di chiusura:
3.27
Precedente Chiudi:
$3.42
Aprire:
$3.42
Volume 24 ore:
24,546
Relative Volume:
0.48
Capitalizzazione di mercato:
$11.12M
Reddito:
$125.00K
Utile/perdita netta:
$-15.75M
Rapporto P/E:
-0.5332
EPS:
-6.1327
Flusso di cassa netto:
$-14.57M
1 W Prestazione:
+6.51%
1M Prestazione:
-8.15%
6M Prestazione:
-52.19%
1 anno Prestazione:
-71.83%
Intervallo 1D:
$3.25
$3.5399
Intervallo di 1 settimana:
$3.03
$3.62
Portata 52W:
$2.99
$41.22
Imunon Inc Stock (IMNN) Company Profile
Nome
Imunon Inc
Settore
Industria
Telefono
(609) 896-9100
Indirizzo
997 LENOX DRIVE, LAWRENCEVILLE
Compare IMNN vs VRTX, REGN, ARGX, ALNY, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
IMNN
Imunon Inc
|
3.27 | 11.63M | 125.00K | -15.75M | -14.57M | -6.1327 |
|
VRTX
Vertex Pharmaceuticals Inc
|
465.02 | 117.03B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
783.65 | 82.35B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
833.54 | 51.64B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
308.48 | 42.58B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
346.42 | 38.87B | 4.98B | 69.60M | 525.67M | 0.5198 |
Imunon Inc Borsa (IMNN) Ultime notizie
FY2025 Earnings Estimate for Imunon Issued By HC Wainwright - Defense World
Imunon stock price target raised to $25 from $14 at H.C. Wainwright By Investing.com - Investing.com South Africa
IMNN: Streamlining Operations to Focus on OVATION 3 - Smartkarma
Rate Hike: Will Imunon Inc outperform its industry peersJuly 2025 Drop Watch & Low Risk Profit Maximizing Plans - baoquankhu1.vn
Imunon stock price target raised to $25 from $14 at H.C. Wainwright - Investing.com Nigeria
Imunon, Inc. Announces Retirement of Executive Vice President and Chief Scientific Officer Khursheed Anwer, Effective February 20, 2026 - marketscreener.com
Imunon sharpens focus on its promising pivotal Phase 3 ovarian cancer study - marketscreener.com
IMUNON rises on plan to shift resources to ovarian cancer therapy - TradingView
Imunon stock rises following strategic restructuring to focus on Phase 3 trial - Investing.com Nigeria
Imunon stock rises following strategic restructuring to focus on Phase 3 trial By Investing.com - Investing.com South Africa
Imunon announces orderly retirement of chief scientific officer - TipRanks
IMUNON, Inc. Announces Strategic Restructuring and Retirement of Chief Scientific Officer to Advance Phase 3 Clinical Trial - Quiver Quantitative
IMUNON SHARPENS FOCUS ON ITS PROMISING PIVOTAL PHASE 3 OVARIAN CANCER STUDY - One News Page
Resistance Check: Is MLTX stock a buy or sellGold Moves & Safe Entry Momentum Tips - baoquankhu1.vn
Stock Analysis: Can Imunon Inc sustain earnings growthTrade Ideas & Pattern Based Trade Signal System - baoquankhu1.vn
Imunon CEO says ‘poised for key milestones’ as company enters 2026 - MSN
Pullback Watch: Can Imunon Inc continue delivering strong returnsQuarterly Earnings Report & Weekly Market Pulse Alerts - baoquankhu1.vn
Aug Mood: What is Franklin BSP Realty Trust Incs debt to equity ratioPortfolio Gains Summary & Fast Gain Swing Alerts - baoquankhu1.vn
Is Imunon Inc. stock a good pick for beginnersQuarterly Earnings Summary & Verified Momentum Watchlists - bollywoodhelpline.com
IPO Launch: Why Imunon Inc stock is recommended by analystsJuly 2025 Volume & AI Driven Stock Price Forecasts - Bộ Nội Vụ
Aug Weekly: What is Five Below Incs revenue forecastPortfolio Performance Summary & Low Risk High Reward Ideas - baoquankhu1.vn
Head to Head Review: Allogene Therapeutics (NASDAQ:ALLO) and Imunon (NASDAQ:IMNN) - Defense World
Market Review: Will Imunon Inc stock deliver shareholder valueWeekly Earnings Recap & Consistent Profit Focused Trading Strategies - Bộ Nội Vụ
Imunon, Inc. (NASDAQ:IMNN) Receives $232.50 Average Price Target from Analysts - Defense World
Can Imunon Inc. stock maintain growth trajectoryMarket Movement Recap & Daily Entry Point Trade Alerts - Улправда
How Imunon Inc. stock performs in stagflationChart Signals & Expert Approved Momentum Trade Ideas - Улправда
Will Imunon Inc. stock deliver shareholder valueMarket Rally & Risk Controlled Stock Pick Alerts - Улправда
Can Imunon Inc. stock attract ESG capital inflowsQuarterly Trade Summary & High Conviction Buy Zone Picks - Улправда
Imunon Announces CFO Transition and Reappointment of Jeffrey Church - The Globe and Mail
Imunon IncInterim CFO Kimberly Graper To Resign January 14, 2026SEC Filing - TradingView — Track All Markets
Imunon, Inc. Announces CFO Transition - TradingView — Track All Markets
Imunon, Inc. Announces Executive Changes, Effective January 14, 2026 - marketscreener.com
Brookline Capital lowers Imunon stock price target to $16 on offering dilution By Investing.com - Investing.com Nigeria
Brookline Capital lowers Imunon stock price target to $16 on offering dilution - Investing.com Nigeria
Market Trends: Can Imunon Inc stock deliver surprise earnings beatWeekly Risk Report & Daily Risk Controlled Trade Plans - Bộ Nội Vụ
Imunon, Inc. Faces Market Volatility: The Impact of Short Selling on Stock Prices - MSN
Imunon Announces $7 Million Registered Direct Offering - TipRanks
Imunon Signs Securities Purchase Agreement With Undisclosed Healthcare-Focused Institutional Investor - TradingView — Track All Markets
IMUNON raises $7 million in registered direct offering By Investing.com - Investing.com Nigeria
Imunon prices 1.94M shares at $3.61 in registered direct offering - TipRanks
Imunon to Raise Roughly $7 Million From Registered Direct Offering - marketscreener.com
IMUNON raises $7 million in registered direct offering - Investing.com
IMUNON Announces Pricing of $7.0 Million Registered Direct Offering Priced At-The-Market Under NASDAQ Rules - GlobeNewswire
IMNN Looks Ahead to Promising 2026 with Key Developments - GuruFocus
IMUNON, Inc. Advances Enrollment in Phase 3 OVATION 3 Study, Paving the Way for Future BLA Filing and Potential Breakthrough in Ovarian Cancer Treatment - Quiver Quantitative
Ovarian cancer drug adds 13 months survival in early trial data - Stock Titan
Fed Meeting: Can Imunon Inc stock attract ESG capital inflowsLayoff News & Daily Chart Pattern Signals - moha.gov.vn
Aug Patterns: Can Imunon Inc CBO stock sustain institutional flowsEarnings Risk Report & Low Risk High Reward Trade Ideas - Bộ Nội Vụ
What analysts say about Imunon Inc stockShort-Term Trading Alerts & Explosive Capital Growth - earlytimes.in
How Imunon Inc. stock performs after earningsEarnings Trend Report & Fast Entry High Yield Stock Tips - Улправда
Imunon Inc Azioni (IMNN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.24%
0.19%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):